Pfizer Inc. (PFE)

43.13
0.23 0.52
NYSE : Health Technology
Prev Close 42.91
Open 42.70
Day Low/High 42.34 / 43.38
52 Wk Low/High 33.20 / 45.81
Volume 16.50M
Avg Volume 21.24M
Exchange NYSE
Shares Outstanding 5.78B
Market Cap 254.98B
EPS 3.60
P/E Ratio 11.02
Div & Yield 1.36 (3.04%)

Latest News

Pfizer Downgraded at BMO

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Jim Cramer: Here's What I Saw That Justified Today's Rally

Jim Cramer: Here's What I Saw That Justified Today's Rally

Some groups that have been in horrendous bear market mode finally caught a bid.

Staying Long Apple Into Tuesday's Product Launch: Market Recon

Staying Long Apple Into Tuesday's Product Launch: Market Recon

My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

It becomes difficult for me to tell you where to run in these markets...

Pfizer Rated New Peer Perform at Wolfe

Tesla Produced A Record Number of Vehicles in Q3, Report Says: LIVE MARKETS BLOG

Tesla Produced A Record Number of Vehicles in Q3, Report Says: LIVE MARKETS BLOG

Tesla produced 80,000 vehicles in the quarter, according to electrek.

Door Hits 2 CEOs in the Behind

We are about a 20 minutes from the open of a new trading week. Futures are up on news of a trade agreement between Canada and the United States that will lessen overall trade tensions and allow the country to focus on China. Tesla up strongly in pre...

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets were higher Tuesday after starting Tuesday's session off in the green.

Drug Companies Start Keeping Prices in Check to Avoid Government Crackdown

Drug Companies Start Keeping Prices in Check to Avoid Government Crackdown

The industry has taken to smaller, voluntary measures to avoid serious federal action on pricing.

Pfizer Reached Our Price Target, So We Could Pause Here Before Heading Higher

Pfizer Reached Our Price Target, So We Could Pause Here Before Heading Higher

Traders should raise sell stops to just above $40 from below $35.50

Jim Cramer: This Is a Rotation, Not a Recession

Jim Cramer: This Is a Rotation, Not a Recession

There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.

Why Pay a Premium for Estee Lauder?

Why Pay a Premium for Estee Lauder?

EL's stock is up despite a guidance cut.

Buy Stocks That Are Down, Not Up, Here

Buy Stocks That Are Down, Not Up, Here

Take a pass on stocks like Kimberly-Clark or Pfizer that are bucking Wednesday's sell-off and going higher.

Best Tech Stocks to Buy -- No Matter What Apple Reports

Best Tech Stocks to Buy -- No Matter What Apple Reports

Tech is still the equity market's leading sector over three months -- and over most timeframes going back years.

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

This market clearly has no clue what to buy, with strong GDP growth but challenging trade dynamics and the Facebook and Twitter bombs last week.

The Race to Cure Alzheimer's is On: These Are the Forerunners

The Race to Cure Alzheimer's is On: These Are the Forerunners

Top pharmaceutical companies are paving the way to a cure for Alzheimer's, a degenerative disease that is affecting millions around the world.

4 Conservative Dividend Stocks That Belong in Every Income Investors Portfolio

4 Conservative Dividend Stocks That Belong in Every Income Investors Portfolio

These blue chips pay shareholders handsomely in the form of dividends and share buybacks.

Jim Cramer: Sometimes You Just Have to Go Against the Grain

Jim Cramer: Sometimes You Just Have to Go Against the Grain

This market is all about being opportunistic.

REPLAY: Jim Cramer on Tariffs, Oil Prices and Pfizer's Reorganization

REPLAY: Jim Cramer on Tariffs, Oil Prices and Pfizer's Reorganization

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending stocks from the floor of the New York Stock Exchange.

Pfizer's China Exposure Could Dampen Its Reshuffle Hopes

Pfizer's China Exposure Could Dampen Its Reshuffle Hopes

For Pfizer, China is third largest market and a growing area of concern.

Pfizer: Why This Blue-Chip Dividend Stock Is a Buy Today

Pfizer: Why This Blue-Chip Dividend Stock Is a Buy Today

We believe the company has double-digit total return potential at its current price.

Pfizer Reorganization Could Set the Stage for Full-Blown Spinoff

Pfizer Reorganization Could Set the Stage for Full-Blown Spinoff

Pfizer reorganization could pave way for the company to spin off businesses.

Jim Cramer Reacts to Pfizer's Reorganization

Jim Cramer Reacts to Pfizer's Reorganization

Pfizer announced plans Wednesday to reorganize into three units.

Pfizer Doesn't Look Fundamentally or Technically Strong

Pfizer Doesn't Look Fundamentally or Technically Strong

The stock faces a lot of headwinds on a day when markets are trying to surmount trade-war woes.

Jim Cramer: The Money Isn't Leaving the Casino

Jim Cramer: The Money Isn't Leaving the Casino

The bets are coming off one table and going to another amid the tariff news, much to the consternation of the sideliners.

Trump's Latest $200 Billion Tariff Threat and 4 Other Stories to Watch Wednesday

Trump's Latest $200 Billion Tariff Threat and 4 Other Stories to Watch Wednesday

Here are the business stories you must know as U.S. stock futures fall sharply.